BE848932A - Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active, - Google Patents
Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active,Info
- Publication number
- BE848932A BE848932A BE172864A BE172864A BE848932A BE 848932 A BE848932 A BE 848932A BE 172864 A BE172864 A BE 172864A BE 172864 A BE172864 A BE 172864A BE 848932 A BE848932 A BE 848932A
- Authority
- BE
- Belgium
- Prior art keywords
- vitro
- inhibitor
- blood
- factor
- active
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 238000000338 in vitro Methods 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96444—Factor X (3.4.21.6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7513495A SE419871B (sv) | 1975-12-01 | 1975-12-01 | Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod |
Publications (1)
Publication Number | Publication Date |
---|---|
BE848932A true BE848932A (fr) | 1977-05-31 |
Family
ID=20326201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE172864A BE848932A (fr) | 1975-12-01 | 1976-11-30 | Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active, |
Country Status (15)
Country | Link |
---|---|
US (1) | US4139415A (fr) |
JP (1) | JPS5915640B2 (fr) |
AT (1) | AT348687B (fr) |
AU (1) | AU508343B2 (fr) |
BE (1) | BE848932A (fr) |
CA (1) | CA1060324A (fr) |
CH (1) | CH625052A5 (fr) |
DE (1) | DE2654189C3 (fr) |
DK (1) | DK537676A (fr) |
FI (1) | FI63494C (fr) |
FR (1) | FR2334109A1 (fr) |
GB (1) | GB1562808A (fr) |
NL (1) | NL7613376A (fr) |
NO (1) | NO148960C (fr) |
SE (1) | SE419871B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2757992A1 (de) | 1977-12-24 | 1979-06-28 | Boehringer Mannheim Gmbh | Verfahren zur prothrombin-bestimmung |
US4302538A (en) * | 1978-03-27 | 1981-11-24 | Ortho Diagnostics Inc. | Buffer system in an anti-thrombin III test |
SE422081B (sv) * | 1979-08-22 | 1982-02-15 | Ird Biomaterial Ab | Sett att pavisa proteolytiska enzymer |
CA1161432A (fr) * | 1980-02-12 | 1984-01-31 | Lars G. Svendsen | Derives de tripeptides et application pour le dosage des enzymes |
WO1982001377A1 (fr) * | 1980-10-09 | 1982-04-29 | Lill Helmut | Procede de determination d'une bm ('binding moderately') antithrombine |
US4753875A (en) * | 1981-11-02 | 1988-06-28 | Ryan James W | Method for assaying proteases with tagged proteinaceous inhibitors |
US5221614A (en) * | 1988-03-03 | 1993-06-22 | Nippon Shoji Kabushiki Kaisha | Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time |
GB9602166D0 (en) * | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
DE19634312A1 (de) * | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma |
US6432658B1 (en) | 2000-09-13 | 2002-08-13 | Affinity Biologicals, Inc. | Method for measuring antithrombin activity |
EP2818871A1 (fr) * | 2013-06-28 | 2014-12-31 | Roche Diagniostics GmbH | Moyens et procédés pour étalonnage universel de tests anti-facteur Xa |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE380257B (sv) * | 1972-05-02 | 1975-11-03 | Bofors Ab | Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser |
US3985618A (en) * | 1975-05-02 | 1976-10-12 | Irving Innerfield | Method for detection of thrombosis and prethrombosis |
-
1975
- 1975-12-01 SE SE7513495A patent/SE419871B/xx unknown
-
1976
- 1976-11-23 US US05/744,227 patent/US4139415A/en not_active Expired - Lifetime
- 1976-11-29 GB GB49679/76A patent/GB1562808A/en not_active Expired
- 1976-11-29 AU AU20061/76A patent/AU508343B2/en not_active Expired
- 1976-11-30 BE BE172864A patent/BE848932A/fr not_active IP Right Cessation
- 1976-11-30 DK DK537676A patent/DK537676A/da unknown
- 1976-11-30 NO NO764081A patent/NO148960C/no unknown
- 1976-11-30 DE DE2654189A patent/DE2654189C3/de not_active Expired
- 1976-11-30 FI FI763446A patent/FI63494C/fi not_active IP Right Cessation
- 1976-11-30 CA CA266,874A patent/CA1060324A/fr not_active Expired
- 1976-12-01 CH CH1514576A patent/CH625052A5/de not_active IP Right Cessation
- 1976-12-01 NL NL7613376A patent/NL7613376A/xx unknown
- 1976-12-01 JP JP51143524A patent/JPS5915640B2/ja not_active Expired
- 1976-12-01 AT AT891076A patent/AT348687B/de not_active IP Right Cessation
- 1976-12-01 FR FR7636233A patent/FR2334109A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
FI763446A (fr) | 1977-06-02 |
SE419871B (sv) | 1981-08-31 |
CH625052A5 (fr) | 1981-08-31 |
SE7513495L (sv) | 1977-06-02 |
FI63494C (fi) | 1983-06-10 |
AT348687B (de) | 1979-02-26 |
NL7613376A (nl) | 1977-06-03 |
AU2006176A (en) | 1978-06-08 |
NO148960C (no) | 1984-01-18 |
JPS5297792A (en) | 1977-08-16 |
DE2654189A1 (de) | 1977-06-08 |
GB1562808A (en) | 1980-03-19 |
DK537676A (da) | 1977-06-02 |
NO148960B (no) | 1983-10-10 |
ATA891076A (de) | 1978-07-15 |
FI63494B (fi) | 1983-02-28 |
DE2654189C3 (de) | 1985-10-03 |
CA1060324A (fr) | 1979-08-14 |
JPS5915640B2 (ja) | 1984-04-10 |
FR2334109B1 (fr) | 1982-03-12 |
US4139415A (en) | 1979-02-13 |
NO764081L (fr) | 1977-06-02 |
FR2334109A1 (fr) | 1977-07-01 |
DE2654189B2 (de) | 1979-03-08 |
AU508343B2 (en) | 1980-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE857722A (fr) | Procede pour la preparation d'ethylene-glycol | |
BE809088A (fr) | Procede pour le fractionnement du sang | |
RO69285A (fr) | Procede pour la preparation du diacetate d'ethyldiene | |
FR2342072A1 (fr) | Composition enzymatique pour le traitement de la cataracte | |
BE860377A (fr) | Procede pour fractionner les elements figures du sang | |
BE848932A (fr) | Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active, | |
RO70854A (fr) | Procede pour la preparation des metha-aryloxybenzaldehydes | |
RO72547A (fr) | Procede pour la preparation des esters 2',3,6'-trichlore-4-cyan-4'-benzoylureidodiphenyliques | |
BE818211A (fr) | Procede pour la determination de la teneur du sang en plasminogene | |
RO70462A (fr) | Procede pour la preparation des 3-halomethylcephem | |
RO72910A (fr) | Procede pour la preparation continue d'acide perpropionique en solution benzenique | |
RO71572A (fr) | Procede pour la preparation des oxycarbamates n-sulphenyles | |
RO71066A (fr) | Procede pour la preparation des 2-chlorsulfinylazetidin-4-ones | |
FR2313380A1 (fr) | Procede pour la preparation de methacrylate de glycidyle | |
BE856740A (fr) | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire | |
RO77935A (fr) | Procede pour la preparation des cis-4a-arylo tahydro-1h-2-pyrinidine s | |
RO72831A (fr) | Procede pour la preparation des fenilpyperazines | |
RO79428A2 (fr) | Composition medicamenteuse pour le traitement des dermatoses | |
PT64691B (fr) | Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques | |
PT66201A (fr) | Procede et composition pour la therapeutique des maladies circulatoires cerebrales | |
RO76126A2 (fr) | PROCEDE POUR LA PREPARATION DES ACIDES ANTHRAQUINONE-2,6 ET 2,7-œISULFONIQUES | |
PT66890B (fr) | Procede pour la preparation des aryloxy-1 amino-3 propanol-2 | |
BE864577A (fr) | Composition et procede pour determiner l'activite transferasique et proteasique | |
RO70052A (fr) | Procede pour la preparation des 7-alcoxy-3-chloremethylecephemes | |
RO83713A (fr) | Procede pour la preparation des haloacylamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: PHARMACIA A.B. Effective date: 19841130 |